TIL therapy
1 abstract
Abstract
Tolerability and response of palliative radiotherapy in patients receiving tumor-infiltrating lymphocyte therapy.Org: School of Medicine, Zhejiang University, Hangzhou, China, University of Louisville, Department of Radiation Oncology, Sichuan Cancer Hospital & Institute, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China, Brown Cancer Center, Tufts University Medical Center,